Literature DB >> 32305444

COVID-19 and racial disparities.

Monica Shah1, Muskaan Sachdeva2, Roni P Dodiuk-Gad3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32305444      PMCID: PMC7162783          DOI: 10.1016/j.jaad.2020.04.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
To the Editor: Epidemiologic evidence of age- and sex-related differences for COVID-19 suggest that males and older adults with underlying health conditions including hypertension, obesity, chronic lung disease, diabetes, and cardiovascular disease have increased vulnerability to COVID-19. To date, the literature is very limited on data exploring racial disparities. On April 8, 2020, the Centers for Disease Control and Prevention published surveillance data of laboratory-confirmed COVID-19–associated hospitalizations in 14 US states. Although 18% of individuals in the catchment population were African American, among those with data on race/ethnicity (n = 580), 33.1% were African American, suggesting that African Americans may be disproportionately affected by COVID-19. These data are consistent with government statistics from cities in the United States showing similar racial disparities. In Chicago, Illinois, African Americans account for only 14.6% of the state's population; however, as of April 9, 2020, 51.5% of COVID-positive patients and 67.3% (n = 132) of those who died were African American. Furthermore, in Michigan, although 33% of patients diagnosed with COVID-19 as of April 9, 2020, were African American, this population makes up only approximately 14.1% of the state population. Ethnic minority groups may have greater risk of infection due to comorbidities, including hypertension in African American populations. Moreover, African Americans are more likely to live in densely populated neighbourhoods of lower socioeconomic status, which may lead to increased exposure from closer contact between individuals, less equitable health care access, and lower rates of COVID-19 testing. Additionally, the US Bureau of Labour Statistics reported that only 19.7% of African American employees can work from home, compared with 29.9% of white employees. African Americans may be more likely to work in occupations included in the essential workforce, such as transportation and food service. Moreover, on April 8, 2020, Oliver Brooks, the President of the National Medical Association representing African American physicians and their patients in the United States, stated, “Many of these jobs also do not provide healthcare coverage, so we are underinsured or uninsured during a health crisis. When adding the underlying health risk factors of heart disease, diabetes, and asthma, the African American population is at the epicenter of this current health crisis.” To gain a thorough understanding of the epidemiology of COVID-19 and to ensure targeted health education and equitable allocation of health care system resources for more vulnerable populations, studies on the race-specific prevalence of COVID-19 and outcomes are crucial. We call for higher-priority assessment of racial and ethnic disparities in COVID-19, which may reduce morbidity and mortality among African Americans. As Brooks stated, “There is still time, but time is running out.”
  1 in total

1.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

Authors:  Shikha Garg; Lindsay Kim; Michael Whitaker; Alissa O'Halloran; Charisse Cummings; Rachel Holstein; Mila Prill; Shua J Chai; Pam D Kirley; Nisha B Alden; Breanna Kawasaki; Kimberly Yousey-Hindes; Linda Niccolai; Evan J Anderson; Kyle P Openo; Andrew Weigel; Maya L Monroe; Patricia Ryan; Justin Henderson; Sue Kim; Kathy Como-Sabetti; Ruth Lynfield; Daniel Sosin; Salina Torres; Alison Muse; Nancy M Bennett; Laurie Billing; Melissa Sutton; Nicole West; William Schaffner; H Keipp Talbot; Clarissa Aquino; Andrea George; Alicia Budd; Lynnette Brammer; Gayle Langley; Aron J Hall; Alicia Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

  1 in total
  40 in total

1.  Race and ethnic variation in college students' allostatic regulation of racism-related stress.

Authors:  Jacob E Cheadle; Bridget J Goosby; Joseph C Jochman; Cara C Tomaso; Chelsea B Kozikowski Yancey; Timothy D Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

2.  An ethics framework for consolidating and prioritizing COVID-19 clinical trials.

Authors:  Michelle N Meyer; Luke Gelinas; Barbara E Bierer; Sara Chandros Hull; Steven Joffe; David Magnus; Seema Mohapatra; Richard R Sharp; Kayte Spector-Bagdady; Jeremy Sugarman; Benjamin S Wilfond; Holly Fernandez Lynch
Journal:  Clin Trials       Date:  2021-02-02       Impact factor: 2.486

Review 3.  Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors:  Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal:  Front Pharmacol       Date:  2020-09-11       Impact factor: 5.810

4.  Confronting Racism in Pain Research: A Call to Action.

Authors:  Calia A Morais; Edwin N Aroke; Janelle E Letzen; Claudia M Campbell; Anna M Hood; Mary R Janevic; Vani A Mathur; Ericka N Merriwether; Burel R Goodin; Staja Q Booker; Lisa C Campbell
Journal:  J Pain       Date:  2022-02-26       Impact factor: 5.383

5.  Social Determinants and Indicators of COVID-19 Among Marginalized Communities: A Scientific Review and Call to Action for Pandemic Response and Recovery.

Authors:  Whitney S Brakefield; Olufunto A Olusanya; Brianna White; Arash Shaban-Nejad
Journal:  Disaster Med Public Health Prep       Date:  2022-05-02       Impact factor: 5.556

Review 6.  Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids.

Authors:  Kevin G Chen; Kyeyoon Park; Jason R Spence
Journal:  Nat Cell Biol       Date:  2021-08-02       Impact factor: 28.824

Review 7.  Exploring different methods to evaluate the impact of basic income interventions: a systematic review.

Authors:  Andrew D Pinto; Melissa Perri; Cheryl L Pedersen; Tatiana Aratangy; Ayu Pinky Hapsari; Stephen W Hwang
Journal:  Int J Equity Health       Date:  2021-06-16

Review 8.  The Many Faces of Innate Immunity in SARS-CoV-2 Infection.

Authors:  Nicholas Hanan; Ronnie L Doud; In-Woo Park; Harlan P Jones; Stephen O Mathew
Journal:  Vaccines (Basel)       Date:  2021-06-04

Review 9.  COVID-19 breakthroughs: separating fact from fiction.

Authors:  Paraminder Dhillon; Manuel Breuer; Natasha Hirst
Journal:  FEBS J       Date:  2020-07-05       Impact factor: 5.622

10.  Contributions of dermatologists to COVID-19 research: A brief systematic review.

Authors:  Yuanzhuo Wang; Rouyu Fang; Hanlin Zhang; Keyun Tang; Qiuning Sun
Journal:  Dermatol Ther       Date:  2020-07-02       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.